EAM Global Investors’s Innoviva INVA Stock Holding History

EAM Global Investors’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-96,579	Closed	-$1.87M	–	218
2022 Q1	$1.87M	Buy	+96,579	New	+$1.73M	0.34%	151

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

EAM Global Investors's INVA Position: Q2 2022 in Review

EAM Global Investors sold out of Innoviva (INVA) in Q2 2022, closing a stake of 96,579 shares — an estimated $1.87M sold.

EAM Global Investors first reported a position in INVA in Q1 2022 and held it in 1 quarter. The position peaked at $1.87M in Q1 2022. 218 funds tracked by Wall St. Rank hold INVA as of Q2 2022.

EAM Global Investors reported no remaining Innoviva position as of Q2 2022 after selling out during the quarter.
EAM Global Investors sold 96,579 Innoviva shares in Q2 2022, an estimated $1.87M.
EAM Global Investors first reported a position in Innoviva in Q1 2022 and held it in 1 quarter.
EAM Global Investors's Innoviva position peaked at $1.87M in Q1 2022.
218 funds tracked by Wall St. Rank held Innoviva as of Q2 2022.

Based on EAM Global Investors's 13F filing for Q2 2022, filed 12 Aug 2022.